Limb-Girdle Muscular Dystrophy Type 1b disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials

MCID: LMB074 MIFTS: 25	Limb-Girdle Muscular Dystrophy Type 1b Categories: Genetic diseases, Metabolic diseases, Muscle diseases, Neuronal diseases, Rare diseases, Respiratory diseases
Genes Variations Tissues Related diseases Publications Expand all tables

Sources

Aliases & Classifications for Limb-Girdle Muscular Dystrophy Type 1b

MalaCards integrated aliases for Limb-Girdle Muscular Dystrophy Type 1b:

Name: Limb-Girdle Muscular Dystrophy Type 1b ²⁰

Limb-Girdle Muscular Dystrophy, Type 1b ²⁹ ⁶

Muscular Dystrophy, Proximal, Type 1b ²⁰ ⁶

Lgmd1b ²⁰ ⁵⁴

Classifications:

MalaCards categories:
Global: Rare diseases Genetic diseases Metabolic diseases
Anatomical: Muscle diseases Neuronal diseases Respiratory diseases

See all MalaCards categories (disease lists)

Sources

Summaries for Limb-Girdle Muscular Dystrophy Type 1b

GARD : ²⁰ Limb-girdle muscular dystrophy type 1B (LGMD1B) is one of many types of limb-girdle muscular dystrophy. These diseases affect the voluntary muscles, which are the muscles that are moved on purpose, such as the arms, legs, fingers, toes, and facial muscles. Specifically, LGMD1B causes muscle weakness in the lower limbs. The muscle weakness typically affects the muscles closest to the center of the body (proximal muscles) such as the upper legs. The disease is progressive, leading to a loss of muscle strength and bulk over a number of years. Limb-girdle muscular dystrophy type 1B is caused by mutations (changes) to the LMNA gene. The disease is inherited in an autosomal dominant manner. A diagnosis of LGMD1B is suspected in people who have signs and symptoms consistent with the disease, and the diagnosis can be confirmed with laboratory tests. While there are not treatments that can reverse the muscle weakness associated with the disease, supportive treatment can decrease the complications.

MalaCards based summary : Limb-Girdle Muscular Dystrophy Type 1b, also known as limb-girdle muscular dystrophy, type 1b, is related to limb-girdle muscular dystrophy and muscular dystrophy. An important gene associated with Limb-Girdle Muscular Dystrophy Type 1b is LMNA (Lamin A/C). Affiliated tissues include skeletal muscle.

Sources

Related Diseases for Limb-Girdle Muscular Dystrophy Type 1b

Diseases in the Limb-Girdle Muscular Dystrophy family:

Diseases related to Limb-Girdle Muscular Dystrophy Type 1b via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 43)

#	Related Disease	Score	Top Affiliating Genes
1	limb-girdle muscular dystrophy	30.7	LMNA CAV3
2	muscular dystrophy	30.7	LMNA CAV3
3	autosomal dominant limb-girdle muscular dystrophy	30.0	LMNA CAV3
4	brugada syndrome	29.9	LMNA CAV3
5	neuromuscular disease	29.5	LMNA CAV3
6	emery-dreifuss muscular dystrophy 2, autosomal dominant	11.5
7	myopathy	10.6
8	charcot-marie-tooth disease, axonal, type 2e	10.4
9	atrial standstill 1	10.3
10	exostoses, multiple, type ii	10.3
11	atrioventricular block	10.3
12	emery-dreifuss muscular dystrophy	10.3
13	dilated cardiomyopathy	10.3
14	lmna-related dilated cardiomyopathy	10.3
15	syncope	10.3
16	atrial standstill	10.3
17	premature aging	10.3
18	dysferlinopathy	9.9
19	dystrophinopathies	9.9
20	limb-girdle muscular dystrophy type 1a	9.9
21	qualitative or quantitative defects of dystrophin	9.9
22	qualitative or quantitative defects of dysferlin	9.9
23	muscular dystrophy, limb-girdle, autosomal dominant 2	9.8	LMNA CAV3
24	autosomal recessive limb-girdle muscular dystrophy	9.8	LMNA CAV3
25	autosomal recessive limb-girdle muscular dystrophy type 2a	9.8	LMNA CAV3
26	autosomal recessive limb-girdle muscular dystrophy type 2d	9.8	LMNA CAV3
27	autosomal recessive limb-girdle muscular dystrophy type 2b	9.8	LMNA CAV3
28	isolated elevated serum creatine phosphokinase levels	9.8	LMNA CAV3
29	intrinsic cardiomyopathy	9.8	LMNA CAV3
30	congenital generalized lipodystrophy	9.8	LMNA CAV3
31	muscle tissue disease	9.8	LMNA CAV3
32	catecholaminergic polymorphic ventricular tachycardia	9.8	LMNA CAV3
33	muscular disease	9.8	LMNA CAV3
34	muscular dystrophy, limb-girdle, autosomal recessive 2	9.8	LMNA CAV3
35	muscular dystrophy, congenital, lmna-related	9.8	LMNA CAV3
36	facioscapulohumeral muscular dystrophy 1	9.8	LMNA CAV3
37	heart conduction disease	9.8	LMNA CAV3
38	walker-warburg syndrome	9.7	LMNA CAV3
39	muscular atrophy	9.7	LMNA CAV3
40	cardiomyopathy, familial hypertrophic, 1	9.7	LMNA CAV3
41	long qt syndrome	9.6	LMNA CAV3
42	congenital myasthenic syndrome	9.6	LMNA CAV3
43	hypertrophic cardiomyopathy	9.5	LMNA CAV3

Graphical network of the top 20 diseases related to Limb-Girdle Muscular Dystrophy Type 1b:

Sources

Symptoms & Phenotypes for Limb-Girdle Muscular Dystrophy Type 1b

Sources

Drugs & Therapeutics for Limb-Girdle Muscular Dystrophy Type 1b

Search Clinical Trials , NIH Clinical Center for Limb-Girdle Muscular Dystrophy Type 1b

Sources

Genetic Tests for Limb-Girdle Muscular Dystrophy Type 1b

Genetic tests related to Limb-Girdle Muscular Dystrophy Type 1b:

#	Genetic test	Affiliating Genes
1	Limb-Girdle Muscular Dystrophy, Type 1b ²⁹

Sources

Anatomical Context for Limb-Girdle Muscular Dystrophy Type 1b

MalaCards organs/tissues related to Limb-Girdle Muscular Dystrophy Type 1b:

⁴⁰

Skeletal Muscle

Sources

Publications for Limb-Girdle Muscular Dystrophy Type 1b

Articles related to Limb-Girdle Muscular Dystrophy Type 1b:

(show top 50) (show all 82)

#	Title	Authors	PMID	Year
1	New intronic splicing mutation in the LMNA gene causing progressive cardiac conduction defects and variable myopathy. ⁶ ⁶¹	Rogozhina Y...Zaklyazminskaya E	27717888	2016
2	Novel LMNA mutations in patients with Emery-Dreifuss muscular dystrophy and functional characterization of four LMNA mutations. ⁶¹ ⁶	Scharner J...Zammit PS	20848652	2011
3	Heart transplantation in 7 patients from a single family with limb-girdle muscular dystrophy caused by lamin A/C mutation. ⁵⁴ ⁶¹ ²⁰	Ambrosi P...Habib G	19446900	2009
4	The lethal phenotype of a homozygous nonsense mutation in the lamin A/C gene. ⁶ ⁵⁴	van Engelen BG...Lammens M	15668447	2005
5	Identification of lamin A/C ( LMNA) gene mutations in Korean patients with autosomal dominant Emery-Dreifuss muscular dystrophy and limb-girdle muscular dystrophy 1B. ⁶¹ ⁶	Ki CS...Kim JW	12032588	2002
6	Properties of lamin A mutants found in Emery-Dreifuss muscular dystrophy, cardiomyopathy and Dunnigan-type partial lipodystrophy. ⁶¹ ⁶	Ostlund C...Worman HJ	11792809	2001
7	Identification of mutations in the gene encoding lamins A/C in autosomal dominant limb girdle muscular dystrophy with atrioventricular conduction disturbances (LGMD1B). ⁶ ⁵⁴	Muchir A...Schwartz K	10814726	2000
8	229th ENMC international workshop: Limb girdle muscular dystrophies - Nomenclature and reformed classification Naarden, the Netherlands, 17-19 March 2017. ⁶	Straub V...LGMD workshop study group	30055862	2018
9	Targeted Re-Sequencing Emulsion PCR Panel for Myopathies: Results in 94 Cases. ⁶	Punetha J...Hoffman EP	27854218	2016
10	Congenital fiber type disproportion myopathy caused by LMNA mutations. ⁶	Kajino S...Hayashi YK	24642510	2014
11	Hypoplasia of the aorta in a patient diagnosed with LMNA gene mutation. ⁶	Coutance G...Chapon F	22883396	2013
12	Genetic analysis in 418 index patients with idiopathic dilated cardiomyopathy: overview of 10 years' experience. ⁶	van Spaendonck-Zwarts KY...van Tintelen JP	23349452	2013
13	Myopathic lamin mutations impair nuclear stability in cells and tissue and disrupt nucleo-cytoskeletal coupling. ⁶	Zwerger M...Lammerding J	23427149	2013
14	Inflammatory changes in infantile-onset LMNA-associated myopathy. ⁶	Komaki H...Nishino I	21632249	2011
15	Lamin A variants that cause striated muscle disease are defective in anchoring transmembrane actin-associated nuclear lines for nuclear movement. ⁶	Folker ES...Gundersen GG	21173262	2011
16	Two children with "dropped head" syndrome due to lamin A/C mutations. ⁶	Chemla JC...Smith EC	20886652	2010
17	Specific phosphorylation of Ser458 of A-type lamins in LMNA-associated myopathy patients. ⁶	Mitsuhashi H...Nishino I	20980393	2010
18	Lamin A rod domain mutants target heterochromatin protein 1alpha and beta for proteasomal degradation by activation of F-box protein, FBXW10. ⁶	Chaturvedi P...Parnaik VK	20498703	2010
19	Defects in cell spreading and ERK1/2 activation in fibroblasts with lamin A/C mutations. ⁶	Emerson LJ...Ellis JA	19524666	2009
20	Germinal mosaicism for LMNA mimics autosomal recessive congenital muscular dystrophy. ⁶	Makri S...Guicheney P	19084400	2009
21	Laminopathies in Russian families. ⁶	Rudenskaya GE...Ginter EK	18564364	2008
22	De novo LMNA mutations cause a new form of congenital muscular dystrophy. ⁶	Quijano-Roy S...Estournet B	18551513	2008
23	Phenotypic clustering of lamin A/C mutations in neuromuscular patients. ⁶	Benedetti S...Previtali SC	17377071	2007
24	Mutations of the LMNA gene can mimic autosomal dominant proximal spinal muscular atrophy. ⁶	Rudnik-Schoneborn S...Zerres K	17136397	2007
25	Expression of disease-causing lamin A mutants impairs the formation of DNA repair foci. ⁶	Manju K...Parnaik VK	16772334	2006
26	Lamin A N-terminal phosphorylation is associated with myoblast activation: impairment in Emery-Dreifuss muscular dystrophy. ⁶	Cenni V...Lattanzi G	15744034	2005
27	Nuclear envelope alterations in fibroblasts from patients with muscular dystrophy, cardiomyopathy, and partial lipodystrophy carrying lamin A/C gene mutations. ⁶	Muchir A...Bonne G	15372542	2004
28	Emery-Dreifuss Muscular Dystrophy ⁶	Bonne G...Ben Yaou R	20301609	2004
29	Extreme variability of phenotype in patients with an identical missense mutation in the lamin A/C gene: from congenital onset with severe phenotype to milder classic Emery-Dreifuss variant. ⁶	Mercuri E...Bushby K	15148145	2004
30	Cardiac features of Emery-Dreifuss muscular dystrophy caused by lamin A/C gene mutations. ⁶	Sanna T...Bellocci F	14659775	2003
31	Mutation analysis of the lamin A/C gene (LMNA) among patients with different cardiomuscular phenotypes. ⁶	Vytopil M...Toniolo D	14684700	2003
32	LMNA mutations in atypical Werner's syndrome. ⁶	Chen L...Oshima J	12927431	2003
33	Expanding the phenotype of LMNA mutations in dilated cardiomyopathy and functional consequences of these mutations. ⁶	Sebillon P...Komajda M	12920062	2003
34	Functional consequences of an LMNA mutation associated with a new cardiac and non-cardiac phenotype. ⁶	Charniot JC...Komajda M	12673789	2003
35	A progeroid syndrome in mice is caused by defects in A-type lamins. ⁶	Mounkes LC...Stewart CL	12748643	2003
36	Clinical relevance of atrial fibrillation/flutter, stroke, pacemaker implant, and heart failure in Emery-Dreifuss muscular dystrophy: a long-term longitudinal study. ⁶	Boriani G...Branzi A	12649505	2003
37	Natural history of dilated cardiomyopathy due to lamin A/C gene mutations. ⁶	Taylor MR...Familial Dilated Cardiomyopathy Registry Research Group	12628721	2003
38	Lamin A/C mutations with lipodystrophy, cardiac abnormalities, and muscular dystrophy. ⁶	van der Kooi AJ...de Visser M	12196663	2002
39	Structure of the globular tail of nuclear lamin. ⁶	Dhe-Paganon S...Shoelson SE	11901143	2002
40	Novel and recurrent mutations in lamin A/C in patients with Emery-Dreifuss muscular dystrophy. ⁶	Brown CA...Spence JE	11503164	2001
41	Clinical and molecular genetic spectrum of autosomal dominant Emery-Dreifuss muscular dystrophy due to mutations of the lamin A/C gene. ⁶	Bonne G...Muntoni F	10939567	2000
42	Different mutations in the LMNA gene cause autosomal dominant and autosomal recessive Emery-Dreifuss muscular dystrophy. ⁶	Raffaele Di Barletta M...Toniolo D	10739764	2000
43	Lamin A/C gene mutation associated with dilated cardiomyopathy with variable skeletal muscle involvement. ⁶	Brodsky GL...Mestroni L	10662742	2000
44	Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy. ⁶	Bonne G...Schwartz K	10080180	1999
45	Genetic localization of a newly recognized autosomal dominant limb-girdle muscular dystrophy with cardiac involvement (LGMD1B) to chromosome 1q11-21. ⁶	van der Kooi AJ...Bolhuis PA	9106535	1997
46	A newly recognized autosomal dominant limb girdle muscular dystrophy with cardiac involvement. ⁶	van der Kooi AJ...de Visser M	8619549	1996
47	In situ hybridization detection of HTLV-I RNA in peripheral blood mononuclear cells of TSP/HAM patients and their spouses. ⁶	Beilke MA...Zaninovic V	1849984	1991
48	Muscle imaging analogies in a cohort of patients with different clinical phenotypes caused by LMNA gene mutations. ⁶¹ ⁵⁴	Carboni N...Marrosu MG	19882644	2010
49	Nuclear changes in skeletal muscle extend to satellite cells in autosomal dominant Emery-Dreifuss muscular dystrophy/limb-girdle muscular dystrophy 1B. ⁶¹ ⁵⁴	Park YE...Nishino I	19070492	2009
50	[Autosomal dominant limb-girdle muscular dystrophy associated with conduction defects (LGMD1B): a description of 8 new families with the LMNA gene mutations]. ⁶¹ ⁵⁴	Ben Yaou R...Bonne G	15678000	2005

Sources

Genes for Limb-Girdle Muscular Dystrophy Type 1b

Genes related to Limb-Girdle Muscular Dystrophy Type 1b (1 elite genes):

- Elite gene

- Cancer Census gene in COSMIC

#	Symbol	Description	Category	Score	Evidence	PubMed IDs
1	LMNA	Lamin A/C	Protein Coding	454.64	Pathogenic ⁶ Likely pathogenic ⁶ Novoseek inferred ⁵⁴ GeneCards inferred via : Publications Variants (show sections)	10080180 10939567 16772334 (more) 20498703 10814726 15678000 19070492 15668447 19446900 11525883 20130076 11799477 15770669 19882644 16481476 11733221 15316618 14673599 11102973
2	CAV3	Caveolin 3	Protein Coding	9.37	Novoseek inferred ⁵⁴	15316618

Sources

Variations for Limb-Girdle Muscular Dystrophy Type 1b

ClinVar genetic disease variations for Limb-Girdle Muscular Dystrophy Type 1b:

⁶ (show top 50) (show all 80)

#	Gene	Name	Type	Significance	ClinVarId	dbSNP ID	Position
1	LMNA	NM_170707.4(LMNA):c.1589T>C (p.Leu530Pro)	SNV	Pathogenic	14482	rs60934003	GRCh37: 1:156107004-156107004 GRCh38: 1:156137213-156137213
2	LMNA	NM_170707.4(LMNA):c.621_623GAA[1] (p.Lys208del)	Microsatellite	Pathogenic	66918	rs267607540	GRCh37: 1:156104300-156104302 GRCh38: 1:156134509-156134511
3	LMNA	NM_170707.4(LMNA):c.1608+5G>C	SNV	Pathogenic	66854	rs267607539	GRCh37: 1:156107028-156107028 GRCh38: 1:156137237-156137237
4	LMNA	NM_170707.4(LMNA):c.936+2T>C	SNV	Pathogenic	208496	rs797045011	GRCh37: 1:156105105-156105105 GRCh38: 1:156135314-156135314
5	LMNA	NM_170707.4(LMNA):c.810+1G>C	SNV	Pathogenic	216958	rs267607632	GRCh37: 1:156104767-156104767 GRCh38: 1:156134976-156134976
6	LMNA	NM_170707.4(LMNA):c.1072G>A (p.Glu358Lys)	SNV	Pathogenic	14525	rs60458016	GRCh37: 1:156105827-156105827 GRCh38: 1:156136036-156136036
7	LMNA	NM_170707.4(LMNA):c.664C>T (p.His222Tyr)	SNV	Pathogenic	14492	rs28928901	GRCh37: 1:156104620-156104620 GRCh38: 1:156134829-156134829
8	LMNA	NM_170707.4(LMNA):c.746G>A (p.Arg249Gln)	SNV	Pathogenic	66931	rs59332535	GRCh37: 1:156104702-156104702 GRCh38: 1:156134911-156134911
9	LMNA	NM_170707.4(LMNA):c.1130G>A (p.Arg377His)	SNV	Pathogenic	14495	rs61672878	GRCh37: 1:156105885-156105885 GRCh38: 1:156136094-156136094
10	LMNA	NM_005572.3(LMNA):c.959delT (p.Arg321Glufs)	Deletion	Pathogenic	14491	rs56771886	GRCh37: 1:156105714-156105714 GRCh38: 1:156135923-156135923
11	LMNA	NM_170707.4(LMNA):c.1580G>C (p.Arg527Pro)	SNV	Pathogenic	14481	rs57520892	GRCh37: 1:156106995-156106995 GRCh38: 1:156137204-156137204
12	LMNA	NM_170707.4(LMNA):c.398G>C (p.Arg133Pro)	SNV	Pathogenic	14508	rs60864230	GRCh37: 1:156100449-156100449 GRCh38: 1:156130658-156130658
13	LMNA	NM_170707.4(LMNA):c.513+45T>G	SNV	Pathogenic	236201	rs878853220	GRCh37: 1:156100609-156100609 GRCh38: 1:156130818-156130818
14	LMNA	NM_170707.4(LMNA):c.674G>A (p.Arg225Gln)	SNV	Pathogenic	41234	rs199474724	GRCh37: 1:156104630-156104630 GRCh38: 1:156134839-156134839
15	LMNA	NM_170707.4(LMNA):c.16C>T (p.Gln6Ter)	SNV	Pathogenic	14477	rs61046466	GRCh37: 1:156084725-156084725 GRCh38: 1:156114934-156114934
16	LMNA	NM_170707.4(LMNA):c.1357C>T (p.Arg453Trp)	SNV	Pathogenic	14478	rs58932704	GRCh37: 1:156106204-156106204 GRCh38: 1:156136413-156136413
17	LMNA	NM_170707.4(LMNA):c.777T>A (p.Tyr259Ter)	SNV	Pathogenic	14511	rs58048078	GRCh37: 1:156104733-156104733 GRCh38: 1:156134942-156134942
18	LMNA	NM_170707.4(LMNA):c.1477C>T (p.Gln493Ter)	SNV	Pathogenic	14514	rs56699480	GRCh37: 1:156106808-156106808 GRCh38: 1:156137017-156137017
19	LMNA	NM_170707.4(LMNA):c.673C>T (p.Arg225Ter)	SNV	Pathogenic	48074	rs60682848	GRCh37: 1:156104629-156104629 GRCh38: 1:156134838-156134838
20	LMNA	NM_170707.4(LMNA):c.1003C>T (p.Arg335Trp)	SNV	Pathogenic	36473	rs386134243	GRCh37: 1:156105758-156105758 GRCh38: 1:156135967-156135967
21	LMNA	NM_170707.4(LMNA):c.1445G>A (p.Arg482Gln)	SNV	Pathogenic	14486	rs11575937	GRCh37: 1:156106776-156106776 GRCh38: 1:156136985-156136985
22	LMNA	NM_170707.4(LMNA):c.745C>T (p.Arg249Trp)	SNV	Pathogenic	14524	rs121912496	GRCh37: 1:156104701-156104701 GRCh38: 1:156134910-156134910
23	LMNA	NM_170707.4(LMNA):c.409C>G (p.Leu137Val)	SNV	Likely pathogenic	858277		GRCh37: 1:156100460-156100460 GRCh38: 1:156130669-156130669
24	LMNA	NM_170707.4(LMNA):c.1357C>T (p.Arg453Trp)	SNV	Likely pathogenic	14478	rs58932704	GRCh37: 1:156106204-156106204 GRCh38: 1:156136413-156136413
25	LMNA	NM_170707.4(LMNA):c.1385A>C (p.Gln462Pro)	SNV	Likely pathogenic	488542	rs1553265999	GRCh37: 1:156106716-156106716 GRCh38: 1:156136925-156136925
26	LMNA	NM_170707.4(LMNA):c.695G>A (p.Gly232Glu)	SNV	Likely pathogenic	66925	rs57207746	GRCh37: 1:156104651-156104651 GRCh38: 1:156134860-156134860
27	LMNA	NM_170707.4(LMNA):c.1583C>A (p.Thr528Lys)	SNV	Likely pathogenic	66849	rs57629361	GRCh37: 1:156106998-156106998 GRCh38: 1:156137207-156137207
28	LMNA	NM_170707.4(LMNA):c.1412G>C (p.Arg471Pro)	SNV	Uncertain significance	617763	rs267607578	GRCh37: 1:156106743-156106743 GRCh38: 1:156136952-156136952
29	LMNA	NM_170707.4(LMNA):c.1445G>T (p.Arg482Leu)	SNV	Uncertain significance	14490	rs11575937	GRCh37: 1:156106776-156106776 GRCh38: 1:156136985-156136985
30	LMNA	NM_005572.3(LMNA):c.-226C>T	SNV	Uncertain significance	292823	rs886045354	GRCh37: 1:156084484-156084484 GRCh38: 1:156114693-156114693
31	LMNA	NM_005572.3(LMNA):c.-210T>C	SNV	Uncertain significance	292825	rs886045356	GRCh37: 1:156084500-156084500 GRCh38: 1:156114709-156114709
32	LMNA	NM_170707.4(LMNA):c.-138T>C	SNV	Uncertain significance	292828	rs886045359	GRCh37: 1:156084572-156084572 GRCh38: 1:156114781-156114781
33	LMNA	NM_170707.4(LMNA):c.-44T>A	SNV	Uncertain significance	873801		GRCh37: 1:156084666-156084666 GRCh38: 1:156114875-156114875
34	LMNA	NM_170707.4(LMNA):c.1756G>A (p.Val586Met)	SNV	Uncertain significance	487635	rs758048062	GRCh37: 1:156108336-156108336 GRCh38: 1:156138545-156138545
35	LMNA	NM_170707.4(LMNA):c.1338T>G (p.Asp446Glu)	SNV	Uncertain significance	876083		GRCh37: 1:156106185-156106185 GRCh38: 1:156136394-156136394
36	LMNA	NM_170707.4(LMNA):c.1358G>A (p.Arg453Gln)	SNV	Uncertain significance	570103	rs267607598	GRCh37: 1:156106205-156106205 GRCh38: 1:156136414-156136414
37	LMNA	NM_170707.4(LMNA):c.953C>T (p.Ala318Val)	SNV	Uncertain significance	586129	rs1212920276	GRCh37: 1:156105708-156105708 GRCh38: 1:156135917-156135917
38	LMNA	NM_170707.4(LMNA):c.1027C>T (p.Arg343Trp)	SNV	Uncertain significance	656550	rs749784223	GRCh37: 1:156105782-156105782 GRCh38: 1:156135991-156135991
39	LMNA	NM_170707.4(LMNA):c.356+12C>A	SNV	Uncertain significance	875747		GRCh37: 1:156085077-156085077 GRCh38: 1:156115286-156115286
40	LMNA	NM_170707.4(LMNA):c.796A>G (p.Thr266Ala)	SNV	Uncertain significance	874034		GRCh37: 1:156104752-156104752 GRCh38: 1:156134961-156134961
41	LMNA	NM_170707.4(LMNA):c.1698+57G>A	SNV	Uncertain significance	292840	rs557334569	GRCh37: 1:156107591-156107591 GRCh38: 1:156137800-156137800
42	LMNA	NM_170707.4(LMNA):c.1698+83G>A	SNV	Uncertain significance	875382		GRCh37: 1:156107617-156107617 GRCh38: 1:156137826-156137826
43	LMNA	NM_170707.4(LMNA):c.295C>A (p.Arg99Ser)	SNV	Uncertain significance	292835	rs886045364	GRCh37: 1:156085004-156085004 GRCh38: 1:156115213-156115213
44	LMNA	NM_170707.4(LMNA):c.514-11C>T	SNV	Uncertain significance	292836	rs886045365	GRCh37: 1:156104183-156104183 GRCh38: 1:156134392-156134392
45	LMNA	NM_170707.4(LMNA):c.937-8C>A	SNV	Uncertain significance	222694	rs751707982	GRCh37: 1:156105684-156105684 GRCh38: 1:156135893-156135893
46	LMNA	NM_170707.4(LMNA):c.1381-5G>A	SNV	Uncertain significance	180405	rs730880133	GRCh37: 1:156106707-156106707 GRCh38: 1:156136916-156136916
47	LMNA	NM_170707.4(LMNA):c.398G>A (p.Arg133Gln)	SNV	Uncertain significance	200934	rs60864230	GRCh37: 1:156100449-156100449 GRCh38: 1:156130658-156130658
48	LMNA	NM_170707.4(LMNA):c.1517A>C (p.His506Pro)	SNV	Uncertain significance	242003	rs878855233	GRCh37: 1:156106932-156106932 GRCh38: 1:156137141-156137141
49	LMNA	NM_170707.4(LMNA):c.471G>A (p.Thr157=)	SNV	Uncertain significance	200936	rs150645079	GRCh37: 1:156100522-156100522 GRCh38: 1:156130731-156130731
50	LMNA	NM_170707.4(LMNA):c.749C>T (p.Ala250Val)	SNV	Uncertain significance	48078	rs397517907	GRCh37: 1:156104705-156104705 GRCh38: 1:156134914-156134914

Sources

Expression for Limb-Girdle Muscular Dystrophy Type 1b

Search GEO for disease gene expression data for Limb-Girdle Muscular Dystrophy Type 1b.

Sources

Pathways for Limb-Girdle Muscular Dystrophy Type 1b

Sources

GO Terms for Limb-Girdle Muscular Dystrophy Type 1b

Biological processes related to Limb-Girdle Muscular Dystrophy Type 1b according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	muscle organ development	GO:0007517	8.62	LMNA CAV3

Sources

Sources for Limb-Girdle Muscular Dystrophy Type 1b

¹ BioSystems

² BitterDB

³ CDC

⁴ Cell Signaling Technology

⁵ ClinicalTrials

⁶ ClinVar

⁷ CNVD

⁸ Cochrane Library

⁹ Cosmic

¹⁰ dbSNP

¹¹ DGIdb

¹² Disease Ontology

¹³ diseasecard

¹⁴ DiseaseEnhancer

¹⁵ DISEASES

¹⁶ DrugBank

¹⁷ EFO

¹⁸ ExPASy

¹⁹ FMA

²⁰ GARD

²¹ GeneAnalytics

²² GeneCards

²³ GeneGo (Thomson Reuters)

²⁴ GeneHancer via GeneCards

²⁵ GeneReviews

²⁶ GenomeRNAi

²⁷ GEO DataSets

²⁸ GO

²⁹ GTR

³⁰ HMDB

³¹ HPO

³² ICD10

³³ ICD10 via Orphanet

³⁴ ICD9CM

³⁵ IUPHAR

³⁶ KEGG

³⁷ LifeMap

³⁸ LncRNADisease

³⁹ LOVD

⁴⁰ MalaCards

⁴¹ MedGen

⁴² MedlinePlus

⁴³ MedlinePlus Genetics

⁴⁴ MeSH

⁴⁵ MESH via Orphanet

⁴⁶ MGI

⁴⁷ miR2Disease

⁴⁸ NCBI Bookshelf

⁴⁹ NCI

⁵⁰ NCIt

⁵¹ NDF-RT

⁵² NIH Clinical Center

⁵³ NINDS

⁵⁴ Novoseek

⁵⁵ Novus Biologicals

⁵⁶ OMIM via Orphanet

⁵⁷ OMIM® (Updated 05-Apr-2021)

⁵⁸ Orphanet

⁵⁹ PathCards

⁶⁰ PharmGKB

⁶¹ PubMed

⁶² PubMed Health

⁶³ QIAGEN

⁶⁴ R&D Systems

⁶⁵ Reactome

⁶⁶ Sino Biological

⁶⁷ SNOMED-CT

⁶⁸ SNOMED-CT via HPO

⁶⁹ Tocris

⁷⁰ UMLS

⁷¹ UMLS via Orphanet

⁷² UniProtKB/Swiss-Prot

⁷³ Wikipedia